The Independent Uganda·3 min read·medium
STUDY: HIV injectable drug offers pregnant, lactating mothers 100% protection
✦AI Summary
A Phase 3 clinical trial has found that the injectable HIV drug Lenacapavir provides 100% protection against infection for pregnant and breastfeeding women. The study confirms that the drug is safe for both mothers and infants, with no dose adjustments required.
Health Leave a comment
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in